Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DHA/ARA Term Infant Formula Negative Findings Cast Doubt On Launches

This article was originally published in The Tan Sheet

Executive Summary

Negative research results relating to DHA/ARA supplementation of term infant formulas could delay the U.S. launch of formulas containing the fatty acids.

You may also be interested in...



Enfamil LIPIL Future “Unique Blend” Claims Should Be Clarified, NAD Says

Mead Johnson should clarify future marketing claims forEnfamil LIPIL to avoid the implication it is the only infant formula on the market fortified with fatty acids DHA and ARA, the National Advertising Division of the Council of Better Business Bureaus says in a recent decision

Enfamil LIPIL Future “Unique Blend” Claims Should Be Clarified, NAD Says

Mead Johnson should clarify future marketing claims forEnfamil LIPIL to avoid the implication it is the only infant formula on the market fortified with fatty acids DHA and ARA, the National Advertising Division of the Council of Better Business Bureaus says in a recent decision

Enfamil LIPIL Future “Unique Blend” Claims Should Be Clarified, NAD Says

Mead Johnson should clarify future marketing claims forEnfamil LIPIL to avoid the implication it is the only infant formula on the market fortified with fatty acids DHA and ARA, the National Advertising Division of the Council of Better Business Bureaus says in a recent decision

Related Content

Topics

UsernamePublicRestriction

Register

PS092902

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel